PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer

BACKGROUND: The triple negative breast cancer (TNBC) paradox marks a major challenge in the treatment-decision making process. TNBC patients generally respond better to neoadjuvant chemotherapy compared to other breast cancer patients; however, they have a substantial higher risk of disease recurren...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Khadairi, Ghaneya, Naik, Adviti, Thomas, Remy, Al-Sulaiti, Boshra, Rizly, Shaheen, Decock, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317205/
https://www.ncbi.nlm.nih.gov/pubmed/30602372
http://dx.doi.org/10.1186/s12967-018-1757-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317205/
https://www.ncbi.nlm.nih.gov/pubmed/30602372
http://dx.doi.org/10.1186/s12967-018-1757-3

Ejemplares similares